$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Thalassemia Global Clinical Trials Review, H2, 2016
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 31 Aug 2016 | 27385 | In Stock
Related Topics: Clinical Trials

Introduction

Thalassemia Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2016" provides an overview of Thalassemia clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Thalassemia Global Clinical Trials Review, H2, 2016

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

    Top Five Countries Contributing to Clinical Trials in Central and South America 13

    Clinical Trials by G7 Countries: Proportion of Thalassemia to Hematological Disorders Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by E7 Countries: Proportion of Thalassemia to Hematological Disorders Clinical Trials 17

    Clinical Trials by Phase in E7 Countries 18

    Clinical Trials in E7 Countries by Trial Status 19

    Clinical Trials by Phase 20

    In Progress Trials by Phase 21

    Clinical Trials by Trial Status 22

    Clinical Trials by End Point Status 23

    Subjects Recruited Over a Period of Time 24

    Clinical Trials by Sponsor Type 25

    Prominent Sponsors 26

    Top Companies Participating in Thalassemia Therapeutics Clinical Trials 27

    Prominent Drugs 29

    Latest Clinical Trials News on Thalassemia 30

    Sep 08, 2016: bluebird bio Opens Phase 3 Study of LentiGlobin Drug Product in Patients with Transfusion-Dependent Beta-Thalassemia 30

    Sep 07, 2016: La Jolla Pharmaceutical Company Reports Positive Results from Phase 1 Study of LJPC-401 30

    Sep 07, 2016: La Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC-401 31

    Clinical Trial Profile Snapshots 32

    Appendix 189

    Abbreviations 189

    Definitions 189

    Research Methodology 190

    Secondary Research 190

    About GlobalData 191

    Contact Us 191

    Disclaimer 191

    Source 192

List Of Tables
in Thalassemia Global Clinical Trials Review, H2, 2016

List of Tables

Thalassemia Therapeutics, Global, Clinical Trials by Region, 2016* 6

Thalassemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Thalassemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Thalassemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Thalassemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Thalassemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Thalassemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12

Thalassemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13

Proportion of Thalassemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14

Thalassemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Thalassemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Thalassemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 17

Thalassemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Thalassemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Thalassemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Thalassemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Thalassemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Thalassemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Thalassemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Thalassemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Thalassemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Thalassemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Thalassemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Thalassemia Global Clinical Trials Review, H2, 2016

List of Figures

Thalassemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Thalassemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Thalassemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Thalassemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Thalassemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Thalassemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Thalassemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12

Thalassemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13

Proportion of Thalassemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14

Thalassemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Thalassemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Thalassemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 17

Thalassemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Thalassemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Thalassemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Thalassemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Thalassemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Thalassemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Thalassemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Thalassemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Thalassemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Thalassemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Thalassemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 190

Additional Details

Publisher

Global Data

Publisher Information

Reference

27385 | GDHC3706CTIDB

Number of Pages

192

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Thalassemia - Pipeline Review, H1 2018
Thalassemia - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healt...
27 Feb 2018 by Global Markets Direct USD $2,000 More Info
Thalassemia -Epidemiology Forecast to 2025
DelveInsight “Thalassemia - Epidemiology Forecast To 2025” provides an overview of the epidemiology ...
10 Oct 2017 by Delve Insight USD $2,750 More Info
Thalassemia - Market Insights, Epidemiology and Market Forecast – 2025
DelveInsight’s “Thalassemia - Market Insights, Epidemiology and Market Forecast - Market Insights, E...
10 Oct 2017 by Delve Insight USD $5,750 More Info
Thalassemia - Pipeline Review, H2 2017
Thalassemia - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healt...
22 Aug 2017 by Global Markets Direct USD $2,000 More Info
Thalassemia - Pipeline Review, H2 2017
Thalassemia - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healt...
22 Aug 2017 by Global Markets Direct USD $2,000 More Info
Thalassemia - Epidemiology Forecast To 2023
DelveInsight “Thalassemia - Epidemiology Forecast To 2023” provides an overview of the epidemiology ...
31 May 2017 by Delve Insight USD $2,750 More Info
Thalassemia-Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Thalassemia - Market Insigh...
30 May 2017 by Delve Insight USD $4,950 More Info
Thalassemia-Pipeline Insights, 2017
DelveInsight’s, “ Thalassemia-Pipeline Insights, 2017”, report provides in depth insights on the pip...
30 May 2017 by Delve Insight USD $1,250 More Info
Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Thalassemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape...
30 May 2017 by Delve Insight USD $2,000 More Info
Thalassemia - Pipeline Review, H1 2017
Thalassemia - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healt...
22 Mar 2017 by Global Markets Direct USD $2,000 More Info

This report is published by Global Data

Download Free Report Summary PDF

Thalassemia Global Clinical Trials Review, H2, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...